John J. Rinehart

Phase I trial of recombinant interleukin 3 before and after carboplatin/etoposide chemotherapy in patients with solid tumors: a southwest oncology group study.

E. Hersh, P. Triozzi, J. Rinehart, 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.

Interleukin-2 therapy enhances salicylate oxidation by blood granulocytes.

P. Triozzi, A. Sagone, R. Husney, 1991, Blood.

Phase I trial of recombinant interleukin 3 before and after carboplatin/etoposide chemotherapy in patients with solid tumors: a southwest oncology group study.

John J. Rinehart, Evan M. Hersh, Marilyn Campion, 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.